Skip to main content
Clinical Trials/NCT00908648
NCT00908648
Completed
Not Applicable

The Impact of Narrow Band Imaging in Screening Colonoscopy: a Randomized Controlled Trial.

Valduce Hospital0 sites206 target enrollmentNovember 2007
ConditionsColonoscopy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colonoscopy
Sponsor
Valduce Hospital
Enrollment
206
Primary Endpoint
Adenoma Detection
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Narrow band imaging (NBI) is an imaging technique that allows a better definition of capillary pattern and improves the contrast between adenomas and the surrounding mucosa. Conflicting data exist on the ability of NBI in to improve detection of colonic neoplasm; the impact of NBI is being tested in several screening scenarios. The investigators evaluated whether the routine use of NBI, compared to white light (WL), during the withdrawal phase of screening colonoscopy improved adenoma detection.

Registry
clinicaltrials.gov
Start Date
November 2007
End Date
April 2008
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Valduce Hospital
Responsible Party
Principal Investigator
Principal Investigator

Vittorio Terruzzi

MD

Valduce Hospital

Eligibility Criteria

Inclusion Criteria

  • 50-69 year-old asymptomatic subjects at average-risk of CRC
  • positive FOBT participating in a national mass-screening program and referred for colonoscopy

Exclusion Criteria

  • ongoing anticoagulation therapy
  • inadequate bowel cleansing
  • incomplete colonoscopy
  • refusing to participate

Outcomes

Primary Outcomes

Adenoma Detection

Time Frame: duration of colonoscopy procedure

Detection of adenoma, defined as the number of patients with \> 1 adenoma, under White Light or NBI visualization

Secondary Outcomes

  • Detection of Flat and/or Depressed Adenomas(duration of colonoscopy procedure)

Similar Trials